Literature DB >> 12064989

Infectious diseases. 6: Sexually transmitted infections: new diagnostic approaches and treatments.

Francis J Bowden1, Sepehr N Tabrizi, Suzanne M Garland, Christopher K Fairley.   

Abstract

1. Commercially available nucleic acid amplification assays (eg, polymerase or ligase chain reaction) are now the "gold standard" tests for genital chlamydial infection and also have a role in screening for gonococcal infection. 2. Single-dose oral antibiotics are available for treatment of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infections. 3. Strains of N. gonorrhoeae in urban Australia are often penicillin resistant, while strains from South East Asia and those in homosexually active men may show high-level resistance to quinolones. 4. Imiquimod, a novel immune-response modifier, is now available for effective, safe, self-administered treatment of genital warts. 5. The Pap smear remains the cornerstone of screening for precursor lesions of cervical cancer, but human papillomavirus genotyping may have a role in clinical decision-making for women with equivocal or early precancerous lesions. 6. Treatment of primary genital herpes changes the clinical course, and long-term suppressive therapy is effective for those with multiple recurrences. New technologies have made diagnosis and screening easier for patients and clinicians

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12064989     DOI: 10.5694/j.1326-5377.2002.tb04554.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  8 in total

Review 1.  The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.

Authors:  Jennifer L Edwards; Michael A Apicella
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  Simultaneous identification of 14 genital microorganisms in urine by use of a multiplex PCR-based reverse line blot assay.

Authors:  Michelle L McKechnie; Richard Hillman; Deborah Couldwell; Fanrong Kong; Eleanor Freedman; Hui Wang; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

Review 3.  Molecular methods in the laboratory diagnosis of sexually transmitted infections.

Authors:  Sumathi Muralidhar
Journal:  Indian J Sex Transm Dis AIDS       Date:  2015 Jan-Jun

4.  STI in remote communities: improved and enhanced primary health care (STRIVE) study protocol: a cluster randomised controlled trial comparing 'usual practice' STI care to enhanced care in remote primary health care services in Australia.

Authors:  James Ward; Skye McGregor; Rebecca J Guy; Alice R Rumbold; Linda Garton; Bronwyn J Silver; Debbie Taylor-Thomson; Belinda Hengel; Janet Knox; Amalie Dyda; Matthew G Law; Handan Wand; Basil Donovan; Christopher K Fairley; Steven Skov; Donna Ah Chee; John Boffa; David Glance; Robyn McDermott; Lisa Maher; John M Kaldor
Journal:  BMC Infect Dis       Date:  2013-09-09       Impact factor: 3.090

5.  Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice.

Authors:  Lisa Natoli; Lisa Maher; Mark Shephard; Belinda Hengel; Annie Tangey; Steven G Badman; James Ward; Rebecca J Guy
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

6.  Rapid Point-of-Care Testing for Genital Tract Inflammatory Cytokine Biomarkers to Diagnose Asymptomatic Sexually Transmitted Infections and Bacterial Vaginosis in Women: Cost Estimation and Budget Impact Analysis.

Authors:  Angela Kairu; Lindi Masson; Jo-Ann S Passmore; Lucy Cunnama; Edina Sinanovic
Journal:  Sex Transm Dis       Date:  2022-03-01       Impact factor: 3.868

Review 7.  Outreach for chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes.

Authors:  Belinda Hengel; Muhammad S Jamil; Jacqueline K Mein; Lisa Maher; John M Kaldor; Rebecca J Guy
Journal:  BMC Public Health       Date:  2013-11-04       Impact factor: 3.295

8.  A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the "TTANGO" trial protocol.

Authors:  Rebecca J Guy; Lisa Natoli; James Ward; Louise Causer; Belinda Hengel; David Whiley; Sepehr N Tabrizi; Basil Donovan; Christopher K Fairley; Steven B Badman; Annie Tangey; Handan Wand; Mark Shephard; David G Regan; David Wilson; David Anderson; John M Kaldor
Journal:  BMC Infect Dis       Date:  2013-10-18       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.